A lack of governance implies a high risk of long-term failure.

Part of the reason it's so difficult to reach long-term goals is because there always seem to be more reasons to give up than there are to go on: fear of failure, lack of time or money and so on.

But the failure nearly two years ago of torcetrapib, an experimental drug from Pfizer, spotlighted the risks of using drugs without long-term data.